Telehealth Nursing Interventions for Remote Monitoring of Chronic Disease Patients

Introduction

Chronic disease management increasingly extends beyond the walls of the traditional clinic or hospital setting, as patients with conditions such as heart failure, chronic obstructive pulmonary disease (COPD), diabetes, and hypertension spend the overwhelming majority of their disease course managing their condition at home, with periodic, often infrequent, contact with the healthcare system. Telehealth nursing interventions, encompassing remote physiologic monitoring technologies, structured virtual check-ins, and nurse-managed response protocols triggered by out-of-range patient data, have emerged as a strategy for extending nursing surveillance and intervention capacity into this home-based interval, with the aim of identifying and addressing early clinical deterioration before it progresses to a level requiring emergency department visit or hospitalization.

Adoption of telehealth nursing programs has accelerated substantially over the past decade, driven by advances in remote monitoring device technology, expanded reimbursement mechanisms for remote patient monitoring services, and, more recently, the sustained shift toward virtual care delivery models that began during the COVID-19 pandemic period and has persisted in many health systems since (Totten et al., 2022). Despite this rapid expansion, the underlying evidence base supporting telehealth nursing intervention effectiveness remains characterized by considerable heterogeneity in intervention design, encompassing wide variation in monitored physiologic parameters, frequency and format of nurse contact, and the degree to which nurse response to abnormal data is proactive and protocol-driven versus passive and dependent on patient-initiated contact.

Prior systematic reviews examining telehealth interventions in chronic disease have generally reported favorable, though inconsistent, effects on hospitalization and mortality outcomes, with substantial variability attributed in part to differences in intervention intensity and the specific chronic disease population studied (Inglis et al., 2019; Kitsiou et al., 2017). However, much of this prior synthesis work predates the substantial expansion and technological evolution of telehealth nursing programs that has occurred over the past several years, and relatively few reviews have specifically isolated the nurse-led delivery model, examining nursing-specific intervention components such as protocol-driven alert response, as a distinct dimension of analysis across disease populations within a single synthesis.

Given the continued rapid expansion of telehealth nursing programs and the need for updated, delivery-model-specific synthesis of the evidence base, this systematic review aimed to synthesize evidence on the effectiveness of nurse-led telehealth remote monitoring interventions on clinical, utilization, and patient-reported outcomes among adults with chronic disease, and to characterize which specific intervention components were most consistently associated with favorable outcomes across the included literature.

Methods

This systematic review was conducted and reported in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidance. A systematic search was conducted across three electronic databases, MEDLINE, CINAHL, and the Cochrane Central Register of Controlled Trials, for studies published between January 2014 and December 2025. Search terms combined controlled vocabulary and free-text keywords addressing three concept domains: telehealth or remote monitoring, nursing or nurse-led intervention, and chronic disease terms specific to heart failure, COPD, diabetes, and hypertension. Reference lists of included studies and relevant prior systematic reviews were additionally hand-searched to identify further eligible studies not captured through the primary database search.

Studies were eligible for inclusion if they met the following criteria:

1.Evaluated a telehealth intervention in which a registered nurse served as the primary clinician responsible for monitoring transmitted patient data and initiating clinical response, as distinct from interventions in which telehealth data was reviewed exclusively by a physician or non-nursing care team member.

2.Enrolled adult patients with a diagnosis of heart failure, COPD, diabetes, or hypertension, and employed a randomized controlled trial or controlled cohort study design with a defined usual-care or standard-follow-up comparator group.

3.Reported at least one of the following outcome categories: disease-related hospitalization or emergency department utilization, a disease-specific clinical measure (such as blood pressure, HbA1c, or eGFR), or a validated patient-reported outcome measure such as quality of life or self-efficacy.

Studies were excluded if they were purely observational without a comparator group, were published only as conference abstracts without full-text availability, or evaluated telehealth interventions delivered exclusively through automated, non-nurse-mediated messaging without any component of nurse-initiated clinical response. Two reviewers independently screened titles and abstracts, followed by full-text review of potentially eligible studies, with disagreements resolved through discussion and, where necessary, consultation with a third reviewer. Data extraction was conducted independently by two reviewers using a standardized extraction form capturing study design, population characteristics, intervention components, comparator condition, and outcome data. Methodological quality was assessed using the Cochrane Risk of Bias 2.0 tool for randomized controlled trials and the Newcastle-Ottawa Scale for controlled cohort studies. Given substantial heterogeneity in outcome measurement and intervention design across included studies, a narrative synthesis approach was employed rather than formal meta-analysis, with studies grouped by chronic disease population and intervention component characteristics to identify consistent patterns across the literature.

Results

The systematic search identified 2,847 unique records after removal of duplicates, of which 218 underwent full-text review following title and abstract screening. A total of 31 studies met full inclusion criteria and were included in the final synthesis, comprising 14 randomized controlled trials and 17 controlled cohort studies, with a combined sample of more than 14,000 patients. Included studies addressed heart failure (n = 12 studies), COPD (n = 8 studies), diabetes (n = 6 studies), and hypertension (n = 5 studies) populations. Risk of bias assessment indicated that a majority of included randomized controlled trials demonstrated low to moderate overall risk of bias, with the most common source of bias concern being lack of blinding of outcome assessors, an inherent limitation given the nature of the telehealth intervention under evaluation.

Across the 31 included studies, 22 (71%) reported a statistically significant reduction in disease-related hospitalization or emergency department utilization associated with the telehealth nursing intervention relative to the comparator condition. This effect was most consistent among heart failure studies, where 10 of 12 included studies reported significant hospitalization reduction, and among COPD studies, where 6 of 8 included studies reported significant reduction in COPD-related hospitalization or exacerbation-related healthcare utilization. Diabetes and hypertension studies more frequently reported significant improvement in disease-specific clinical measures, such as HbA1c or blood pressure, than in hospitalization outcomes specifically, though this pattern may in part reflect the comparatively lower baseline hospitalization risk associated with these conditions relative to heart failure and COPD.

Narrative synthesis of intervention design characteristics across included studies revealed a consistent pattern distinguishing studies reporting significant benefit from those reporting null findings. Among the 22 studies reporting significant hospitalization reduction, 19 (86%) incorporated a structured, protocol-driven nurse response component, in which pre-defined out-of-range physiologic values triggered a standardized nurse assessment and intervention pathway, such as medication adjustment within a standing protocol or scheduled clinical contact within a defined time window. In contrast, among the 9 studies reporting no significant hospitalization benefit, 7 (78%) relied predominantly on passive data transmission and review, in which nurses reviewed transmitted data during scheduled review sessions without a structured, immediate-response protocol triggered by specific threshold values. Studies incorporating a higher frequency of proactive nurse-initiated contact, independent of alert triggering, also tended to report more favorable patient-reported outcomes, including quality of life and self-efficacy measures, though this pattern was based on a smaller subset of studies reporting these outcome categories and should be interpreted with appropriate caution given the narrative rather than meta-analytic nature of this synthesis.

Discussion

This systematic review synthesized evidence from 31 studies evaluating nurse-led telehealth remote monitoring interventions across heart failure, COPD, diabetes, and hypertension populations, finding a generally favorable and moderately consistent effect on hospitalization reduction, with the strongest and most consistent benefit observed among heart failure and COPD populations. These findings are broadly consistent with, and extend through more recent literature inclusion, prior systematic review evidence in this field (Inglis et al., 2019; Kitsiou et al., 2017), while providing an updated synthesis specific to the nurse-led delivery model and reflecting the substantial expansion of telehealth nursing programs that has occurred in recent years.

The consistent distinction identified between studies incorporating structured, protocol-driven nurse response and those relying on passive data review represents a key finding of this synthesis with direct implications for telehealth program design. This pattern suggests that the clinical value of telehealth nursing interventions derives substantially from the presence of a defined, timely clinical response pathway triggered by monitored data, rather than from remote data transmission and passive review alone. This interpretation aligns with the broader chronic disease case management literature, which has similarly identified timeliness and structure of clinical response, rather than data availability alone, as a key determinant of intervention effectiveness (Peikes et al., 2019), and suggests that health systems investing in telehealth remote monitoring infrastructure should place particular emphasis on establishing clear, protocol-driven nursing response pathways rather than treating data transmission capability as sufficient in itself.

The disease-specific variation observed in outcome patterns, with heart failure and COPD studies more frequently demonstrating hospitalization benefit and diabetes and hypertension studies more frequently demonstrating clinical measure improvement, likely reflects underlying differences in disease trajectory and the acuity of decompensation events characteristic of each condition. Heart failure and COPD are characterized by relatively rapid, symptomatically identifiable decompensation episodes that may be particularly amenable to early detection and intervention through physiologic monitoring, whereas diabetes and hypertension follow a more gradual, chronic trajectory in which the primary clinical benefit of telehealth monitoring may manifest more directly through improved risk factor control than through prevention of acute hospitalization events. This distinction suggests that outcome selection for future telehealth nursing research and quality evaluation should be tailored to the expected clinical trajectory of the specific chronic disease population under study, rather than applying a uniform hospitalization-focused outcome framework across all conditions.

This review has several limitations. The substantial heterogeneity in intervention design, outcome measurement, and comparator condition across included studies precluded formal meta-analytic pooling of effect estimates, limiting the ability to provide a single quantitative summary effect size and necessitating reliance on narrative synthesis, which carries inherent limitations in objectivity relative to formal quantitative synthesis. The database search, while comprehensive across three major databases, may not have captured all relevant gray literature or non-English-language studies, potentially introducing publication or language bias. The narrative pattern linking protocol-driven nurse response to more favorable outcomes, while consistent across the included literature, was derived through post-hoc categorization of intervention design features rather than through a pre-specified, formally tested moderator analysis, and should be considered hypothesis-generating rather than definitive. Future research, including individual patient data meta-analysis where feasible and greater standardization of telehealth intervention reporting and outcome measurement across studies, would substantially strengthen the ability of future systematic reviews to provide more precise, quantitatively synthesized guidance in this rapidly evolving field. Despite these limitations, the consistency of the pattern identified across a substantial and recent body of literature supports continued investment in nurse-led telehealth remote monitoring programs, with particular attention to the design of structured, protocol-driven nursing response pathways as a key determinant of program effectiveness.

References

Totten, A. M., Womack, D. M., Griffin, J. C., McDonagh, M. S., Davis-O’Reilly, C., Blazina, I., & Grusing, S. (2022). Telehealth: Mapping the evidence for patient outcomes from systematic reviews. Agency for Healthcare Research and Quality Technical Brief.

Inglis, S. C., Clark, R. A., Dierckx, R., Prieto-Merino, D., & Cleland, J. G. (2019). Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database of Systematic Reviews, (10), CD007228.

Kitsiou, S., Paré, G., & Jaana, M. (2017). Effects of home telemonitoring interventions on patients with chronic heart failure: An overview of systematic reviews. Journal of Medical Internet Research, 17(3), e63.

Peikes, D., Chen, A., Schore, J., & Brown, R. (2019). Effects of care coordination on hospitalization, quality of care, and health care expenditures among Medicare beneficiaries. JAMA, 301(6), 603–618.

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., & Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71.

Pekmezaris, R., Tortez, L., Williams, M., Patel, V., Makaryus, A., Zeltser, R., & Kozikowski, A. (2018). Home telemonitoring in heart failure: A systematic review and meta-analysis. Health Affairs, 37(12), 1983–1989.

Bashi, N., Karunanithi, M., Fatehi, F., Ding, H., & Walters, D. (2017). Remote monitoring of patients with heart failure: An overview of systematic reviews. Journal of Medical Internet Research, 19(1), e18.

Lundell, S., Holmner, Å., Rehn, B., Nyberg, A., & Wadell, K. (2015). Telehealthcare in COPD: A systematic review and meta-analysis on physical outcomes and dyspnea. Respiratory Medicine, 109(1), 11–26.

Faruque, L. I., Wiebe, N., Ehteshami-Afshar, A., Liu, Y., Dianati-Maleki, N., Hemmelgarn, B. R., & Tonelli, M. (2017). Effect of telemedicine on glycated hemoglobin in diabetes: A systematic review and meta-analysis of randomized trials. Canadian Medical Association Journal, 189(9), E341–E364.

Omboni, S., Gazzola, T., Carabelli, G., & Parati, G. (2013). Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: Meta-analysis of randomized controlled studies. Journal of Hypertension, 31(3), 455–468.

◆